Lentiviral siRNA silencing of sphingosine-1-phosphate receptors S1P1 and S1P2 in smooth muscle

Biochemical and Biophysical Research Communications

Volumn 343, Issue 4, 2006, Pages 1038-1044

  Hu, Wenhui ^a,b   Huang, Jiean ^a,b   Mahavadi, Sunila ^a,b   Li, Fang ^a,b   Murthy, Karnam S ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lentiviral vector; PLC ; Rho kinase; S1P receptors; siRNA; Smooth muscle contraction; Sphingosine 1 phosphate

Indexed keywords

LENTIVIRUS VECTOR; RECEPTOR SUBTYPE; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE RECEPTOR; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1-PHOSPHATE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; GENE CONSTRUCT; GENE SEQUENCE; GENE SILENCING; IMMUNOCYTOCHEMISTRY; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; GENE VECTOR; GENETICS; IMMUNOHISTOCHEMISTRY; LENTIVIRINAE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; RABBIT; SMOOTH MUSCLE FIBER;

MAMMALIA;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; GENE SILENCING; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; LYSOPHOSPHOLIPIDS; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; RABBITS; RECEPTORS, LYSOSPHINGOLIPID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SPHINGOSINE;

EID: 33744975705     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.079     Document Type: Article

References (34)

1. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23 (2005) 127-159
2. Watterson K.R., Ratz P.H., and Spiegel S. The role of sphingosine-1-phosphate in smooth muscle contraction. Cell Signal. 17 (2005) 289-298
3. Colombaioni L., and Garcia-Gil M. Sphingolipid metabolites in neural signalling and function. Brain Res. Brain Res. Rev. 46 (2004) 328-355
4. Zhou H., and Murthy K.S. Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. Am. J. Physiol. Cell Physiol. 286 (2004) C1130-C1138
5. Ohmori T., Yatomi Y., Osada M., Kazama F., Takafuta T., Ikeda H., and Ozaki Y. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc. Res. 58 (2003) 170-177
6. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., Spiegel S., and Proia R.L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106 (2000) 951-961
7. Kono M., Mi Y., Liu Y., Sasaki T., Allende M.L., Wu Y.P., Yamashita T., and Proia R.L. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem. 279 (2004) 29367-29373
8. Ishii I., Ye X., Friedman B., Kawamura S., Contos J.J., Kingsbury M.A., Yang A.H., Zhang G., Brown J.H., and Chun J. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J. Biol. Chem. 277 (2002) 25152-25159
9. Ishii I., Friedman B., Ye X., Kawamura S., McGiffert C., Contos J.J., Kingsbury M.A., Zhang G., Brown J.H., and Chun J. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J. Biol. Chem. 276 (2001) 33697-33704
10. MacLennan A.J., Devlin B.K., Marks L., Gaskin A.A., Neitzel K.L., and Lee N. Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth. Dev. Neurosci. 22 (2000) 283-295
11. Kimura T., Tomura H., Mogi C., Kuwabara A., Ishiwara M., Shibasawa K., Sato K., Ohwada S., Im D.S., Kurose H., Ishizuka T., Murakami M., and Okajima F. Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signallings for expression of adhesion molecules in endothelial cells. Cell Signal. 18 (2006) 841-850
12. Goparaju S.K., Jolly P.S., Watterson K.R., Bektas M., Alvarez S., Sarkar S., Mel L., Ishii I., Chun J., Milstien S., and Spiegel S. The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol. Cell. Biol. 25 (2005) 4237-4249
13. Bolick D.T., Srinivasan S., Kim K.W., Hatley M.E., Clemens J.J., Whetzel A., Ferger N., Macdonald T.L., Davis M.D., Tsao P.S., Lynch K.R., and Hedrick C.C. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 976-981
14. Finigan J.H., Dudek S.M., Singleton P.A., Chiang E.T., Jacobson J.R., Camp S.M., Ye S.Q., and Garcia J.G. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J. Biol. Chem. 280 (2005) 17286-17293
15. Feistritzer C., and Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105 (2005) 3178-3184
16. Chae S.S., Paik J.H., Furneaux H., and Hla T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J. Clin. Invest. 114 (2004) 1082-1089
17. Lepley D., Paik J.H., Hla T., and Ferrer F. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res. 65 (2005) 3788-3795
18. Donati C., Meacci E., Nuti F., Becciolini L., Farnararo M., and Bruni P. Sphingosine 1-phosphate regulates myogenic differentiation: a major role for S1P2 receptor. FASEB J. 19 (2005) 449-451
19. Krump-Konvalinkova V., Yasuda S., Rubic T., Makarova N., Mages J., Erl W., Vosseler C., Kirkpatrick C.J., Tigyi G., and Siess W. Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 546-552
20. Tiscornia G., Tergaonkar V., Galimi F., and Verma I.M. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101 (2004) 7347-7351
21. Morris K.V., and Rossi J.J. Lentiviral-mediated delivery of siRNAs for antiviral therapy. Gene Ther. (2006)
22. Matta H., Hozayev B., Tomar R., Chugh P., and Chaudhary P.M. Use of lentiviral vectors for delivery of small interfering RNA. Cancer Biol. Ther. 2 (2003) 206-210
23. Abbas-Terki T., Blanco-Bose W., Deglon N., Pralong W., and Aebischer P. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13 (2002) 2197-2201
24. Hu W.H., Pendergast J.S., Mo X.M., Brambilla R., Bracchi-Ricard V., Li F., Walters W.M., Blits B., He L., Schaal S.M., and Bethea J.R. NIBP: a novel NIK and IKKbeta binding protein that enhances NF-kappa B activation. J. Biol. Chem. (2005)
25. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
26. Follenzi A., and Naldini L. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol. 346 (2002) 454-465
27. Murthy K.S., and Makhlouf G.M. Differential coupling of muscarinic m2 and m3 receptors to adenylyl cyclases V/VI in smooth muscle. Concurrent M2-mediated inhibition via Galphai3 and m3-mediated stimulation via Gbetagammaq. J. Biol. Chem. 272 (1997) 21317-21324
28. Murthy K.S., and Makhlouf G.M. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Mol. Pharmacol. 50 (1996) 870-877
29. Murthy K.S., Zhou H., Grider J.R., Brautigan D.L., Eto M., and Makhlouf G.M. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. Biochem. J. 374 (2003) 145-155
30. Murthy K.S. Signaling for contraction and relaxation in smooth muscle of the gut. Annu. Rev. Physiol. 68 (2006) 345-374
31. Zernecke A., Schober A., Bot I., von Hundelshausen P., Liehn E.A., Mopps B., Mericskay M., Gierschik P., Biessen E.A., and Weber C. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 96 (2005) 784-791
32. Cefai D., Simeoni E., Ludunge K.M., Driscoll R., von Segesser L.K., Kappenberger L., and Vassalli G. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo. J. Mol. Cell. Cardiol. 38 (2005) 333-344
33. Dishart K.L., Denby L., George S.J., Nicklin S.A., Yendluri S., Tuerk M.J., Kelley M.P., Donahue B.A., Newby A.C., Harding T., and Baker A.H. Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy. J. Mol. Cell. Cardiol. 35 (2003) 739-748
34. Usui S., Sugimoto N., Takuwa N., Sakagami S., Takata S., Kaneko S., and Takuwa Y. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5. J. Biol. Chem. 279 (2004) 12300-12311